Kannabinoide berriaksegurtasun eta eraginkortasun terapeutikoaren bila

1. Erik Aostri
2. Joseba Pineda
3. Aitziber Mendiguren

Esportatu

Esportatu

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Esportatu

×

Dokumentua ezin da beste atari batetik esportatu.

Testu osoa

lock_openTestu osoa externo

DOI: 10.1387/EKAIA.16320 DIALNET GOOGLE SCHOLAR lock_openSarbide irekia editor

Beste argitalpen batzuk: Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria

Laburpena

Cannabis sativa plant contains non-psychoactive phytocannabinoids including cannabidiol, cannabigerol or Δ9-tetrahydrocannabivarin. Unlike classical cannabinoids (i.e Δ9-THC) most of these compounds bind with low affinity to cannabinoid receptors (CB), which seems to be the reason for their lack of psychoactive effect. Preliminary studies performed in humans and animals demonstrated that these cannabinoids have therapeutic properties. Different targets and mechanisms have been proposed to explain their effects such as activation of serotonergic receptors or modulation of different enzymes.

Datuen iturria: Dialnet